FILAMENT HEALTH CORP. Financials Filament Health Corp.
Equities
FLHLF
CA31685W1068
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0335 USD | +0.15% |
|
+11.67% | -38.08% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 47.3 | 14.9 | 15.14 |
| Enterprise Value (EV) 1 | 43.59 | 13.3 | 14.76 |
| P/E ratio | -4.56 x | -0.88 x | -2.53 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | 4,08,68,758 x | 71,02,600 x |
| EV / Revenue | - | 3,64,98,373 x | 69,28,373 x |
| EV / EBITDA | -60,45,236 x | -25,80,684 x | -33,26,409 x |
| EV / FCF | -2,02,05,606 x | -46,86,026 x | -62,87,894 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 2.86 x | 4.67 x | 6.08 x |
| Nbr of stocks (in thousands) | 1,64,757 | 1,74,949 | 2,11,210 |
| Reference price 2 | 0.2871 | 0.0851 | 0.0717 |
| Announcement Date | 31/03/22 | 31/03/23 | 02/04/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales | - | - | 0.3645 | 2.131 |
| EBITDA | - | -7.211 | -5.155 | -4.438 |
| EBIT 1 | -0.1911 | -7.269 | -5.22 | -4.511 |
| Operating Margin | - | - | -1,432.01% | -211.7% |
| Earnings before Tax (EBT) 1 | -0.1911 | -9.291 | -16.54 | -5.322 |
| Net income 1 | -0.1911 | -9.254 | -16.47 | -5.322 |
| Net margin | - | - | -4,517.55% | -249.75% |
| EPS | - | -0.0629 | -0.0971 | -0.0284 |
| Free Cash Flow | - | -2.157 | -2.839 | -2.348 |
| FCF margin | - | - | -778.88% | -110.19% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 31/03/22 | 31/03/22 | 31/03/23 | 02/04/24 |
1CAD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 0.126 | 0.0239 | 0.1256 | - | 0.246 | 1.275 | 0.2183 |
| EBITDA 1 | - | - | - | - | - | - | -0.8448 | -0.7849 | -0.5481 |
| EBIT 1 | -1.825 | - | - | - | - | - | -0.8757 | -0.8241 | -0.5871 |
| Operating Margin | - | - | - | - | - | - | -356.03% | -64.64% | -268.99% |
| Earnings before Tax (EBT) | -1.929 | - | - | - | - | - | - | - | - |
| Net income | -1.899 | - | - | - | - | -1.131 | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| EPS | -0.008010 | -0.007750 | -0.007750 | -0.007480 | -0.0517 | -0.007430 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 10/11/22 | 31/03/23 | 14/08/23 | 14/11/23 | 02/04/24 | 14/05/24 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | 0.88 | 3.71 | 1.59 | 0.37 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | -2.16 | -2.84 | -2.35 |
| ROE (net income / shareholders' equity) | - | -107% | -167% | -187% |
| ROA (Net income/ Total Assets) | - | -48.5% | -28.9% | -54.7% |
| Assets 1 | - | 19.07 | 56.99 | 9.737 |
| Book Value Per Share 2 | 0.0200 | 0.1000 | 0.0200 | 0.0100 |
| Cash Flow per Share 2 | 0.0200 | 0.0300 | 0.0200 | 0.0100 |
| Capex | - | 0.13 | 0.03 | 0.06 |
| Capex / Sales | - | - | 8.82% | 2.71% |
| Announcement Date | 31/03/22 | 31/03/22 | 31/03/23 | 02/04/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -38.08% | 8.49M | |
| +3.55% | 213B | |
| +8.62% | 188B | |
| +31.58% | 157B | |
| +33.03% | 113B | |
| +5.25% | 64.85B | |
| +22.26% | 55.17B | |
| +1.34% | 49.1B | |
| -5.93% | 38.83B | |
| +2.12% | 35.6B |
- Stock Market
- Equities
- FLHLF Stock
- Financials Filament Health Corp.
